The near-certain trader consensus on "No" stems primarily from the lack of any new SARS-CoV-2 lineage meeting WHO criteria for a variant of concern since 2023, despite continuous genomic surveillance through 2026. Circulating Omicron subvariants such as XFG and NB.1.8.1 have prompted vaccine updates for the 2026-2027 season, yet they remain classified only as variants under monitoring with limited evidence of major immune escape, higher transmissibility, or increased severity. Public health agencies report stable case trends and no escalation in hospitalizations linked to emerging strains like BA.3.2. A realistic shift before 2027 would require rapid global spread of a highly divergent variant triggering a formal VOC designation, an event that has not occurred amid ongoing but contained viral evolution.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · Updated$244,719 Vol.
$244,719 Vol.
$244,719 Vol.
$244,719 Vol.
The CDC's variant classification scheme can be found here: https://stacks.cdc.gov/view/cdc/107682.
The resolution source for this market will be official information from the CDC.
Market Opened: Dec 1, 2025, 4:49 PM ET
Resolver
0x65070BE91...The CDC's variant classification scheme can be found here: https://stacks.cdc.gov/view/cdc/107682.
The resolution source for this market will be official information from the CDC.
Resolver
0x65070BE91...The near-certain trader consensus on "No" stems primarily from the lack of any new SARS-CoV-2 lineage meeting WHO criteria for a variant of concern since 2023, despite continuous genomic surveillance through 2026. Circulating Omicron subvariants such as XFG and NB.1.8.1 have prompted vaccine updates for the 2026-2027 season, yet they remain classified only as variants under monitoring with limited evidence of major immune escape, higher transmissibility, or increased severity. Public health agencies report stable case trends and no escalation in hospitalizations linked to emerging strains like BA.3.2. A realistic shift before 2027 would require rapid global spread of a highly divergent variant triggering a formal VOC designation, an event that has not occurred amid ongoing but contained viral evolution.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · Updated



Beware of external links.
Beware of external links.
Frequently Asked Questions